Blog - Page 2 of 5734 - QualityStocks

FridaySep 11, 2026 1:02 pm

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Integrates Tools, Training and AI for Modern Public Safety

Wrap Technologies (NASDAQ: WRAP) is developing an integrated public safety platform that combines non-lethal response tools, immersive training, evidence management and policy frameworks. At the center is the BolaWrap 150, a remote restraint device designed to help officers respond to non-compliant individuals while maintaining distance, supported by Wrap Reality VR training, Wrap Tactics digital instruction and Wrap Vision evidence management. The company is expanding its platform with AI-enabled WrapShield, designed to integrate sensing, threat detection, decision support, command-and-control and graduated response, initially targeting counter-unmanned aircraft applications. With its technology reportedly deployed by more than 1,000 law enforcement agencies across 60-plus countries,…

FridaySep 11, 2026 12:10 pm

QualityStocksNewsBreaks – Stewards, Inc. (NASDAQ: SWRD) Receives Approval to Uplist to Nasdaq Capital Market

Stewards (NASDAQ: SWRD),a diversified financial platform spanning private credit, real assets and technology-enabled financial infrastructure, received approval from the Listing Qualifications Department of The Nasdaq Stock Market LLC to list its common stock on the Nasdaq Capital Market. The company said its shares will begin trading under the existing “SWRD” ticker through a direct uplisting, with no concurrent public offering or issuance of new shares. Stewards’ private credit platform has originated more than $153 million in cumulative direct and syndicated funding across more than 10,000 small businesses since 2020, while the company has also expanded into income-producing real assets and…

FridaySep 11, 2026 11:31 am

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Reports First Half 2026 Results, Advances GelrinC(R) Pivotal Trial

Regentis Biomaterials (NYSE American: RGNT), a regenerative medicine company focused on innovative tissue repair solutions, reported financial results for the six months ended June 30, 2026 and provided a corporate and clinical update. The company has recruited and treated 43 of 80 patients in its pivotal Phase III GelrinC(R) U.S. trial and now expects to complete enrollment around year-end. Regentis also expanded its U.S. and European clinical networks, advanced preparations for European commercialization and received regulatory approval in Europe for a new solvent-free manufacturing process that increases GelrinC(R) production yield by 400%. For the first half, Regentis reported a net loss of approximately $2.6 million, or $0.44 per share, compared…

FridaySep 11, 2026 11:15 am

Frontieras North America Inc. Puts Mason County at Center of Coal Workforce Revival

Energy security depends on more than pipelines, plants and reserves. It depends on experienced people who know how to run and manage them. Frontieras’s Mason County project is expected to create approximately 200 full-time jobs, with wages averaging three times the average income for the area, along with roughly 2,000 construction jobs during the build phase. The plant itself will process 7,500 tons of coal per day using FASForm(TM), the company's Solid Carbon Fractionation process, producing diesel, naphtha, aviation fuel, hydrogen, methane and FASCarbon(TM), a clean-coal product. A domestic energy project only strengthens the country if it first strengthens the…

FridaySep 11, 2026 10:30 am

QualityStocksNewsBreaks – Vertical Data Inc. (OTCQB: VDTA) Enters Definitive Agreement to Acquire 4.5 MW Data Center Site in Sweden

Vertical Data (OTCQB: VDTA), a vertically integrated AI infrastructure company providing GPU financing, AI hardware, sovereign cloud and edge data center solutions, entered into a definitive purchase agreement through its majority-owned Vertical Data Nordic AB to acquire an existing industrial data center site with 4.5 MW of power capacity in Sollefteå Municipality in Central Sweden. If the transaction proceeds, Vertical Data intends to continue pursuing an application for up to 100 MW of total power capacity to build out an AI data center facility. The company said the project is among several in an active conversion pipeline representing more than 250 MW of global data center opportunities.…

FridaySep 11, 2026 10:30 am

Cheaper Drones Are Exposing a New Weakness in Counter-UAS Defense

The economics of drone warfare are changing rapidly, with inexpensive unmanned systems creating an increasingly difficult cost equation for traditional counter-UAS defenses. At the same time, fiber-optic-guided and autonomous drones can operate without the radio-frequency emissions that many conventional detection and jamming approaches depend on. Wrap Technologies Inc. (NASDAQ: WRAP) is addressing both challenges through WrapShield(TM), combining Frenel Imaging Ltd.’s physics-based sensing technology with laser-directed energy for counter-UAS applications. Drones have become an increasingly important tool in modern military operations, providing intelligence, surveillance and strike capabilities while reducing the need to put personnel directly in harm’s way. As these systems…

FridaySep 11, 2026 10:22 am

QualityStocksNewsBreaks – Nanox Imaging Ltd. (NASDAQ: NNOX) Signs Nanox.ARC Distribution Agreement for Costa Rica

Nanox (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. SOLME will oversee marketing, distribution, installation, training and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (“CCSS”), the country principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration, and Costa Rica represents Nanox third Latin American market this year…

FridaySep 11, 2026 9:45 am

Greenland Mines Ltd. (NASDAQ: GRML) Key Points to Watch Include Rare Earths Closing, Drill Results and Growing AnorTech Stake

Completion of Sarfartoq acquisition announced following formal approval from Greenland government. The 2026 Skaergaard field season is now in its active phase and should generate results before the Arctic season ends. An updated Sarfartoq resource estimate is in progress, and AnorTech stake option is worth tracking closely. Every small-cap mining stock eventually reaches a stretch where several catalysts line up in close succession. That stretch turns a quiet chart into something worth watching closely. For Greenland Mines (NASDAQ: GRML) that stretch is now. Four items are converging: the close of its rare earths acquisition following government approval, the end of…

FridaySep 11, 2026 9:20 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial on Lucid-MS Phase 2 Trial

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) announced its placement in a BioMedWire editorial examining the potential of Lucid-MS to address limitations of existing multiple sclerosis (“MS”) treatments. The editorial highlights Quantum BioPharma’s U.S. Food and Drug Administration (“FDA”) clearance to launch a phase 2 trial of Lucid-MS, a patented, first-in-class candidate designed to protect and potentially rebuild the myelin sheath rather than suppress the immune system. According to the publication, the trial would mark the first time a drug based on this mechanism is tested in people…

FridaySep 11, 2026 9:00 am

Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair

Researchers across the field, from Duke University to Mayo Clinic, are increasingly focused on restoring damaged cartilage rather than simply managing the symptoms associated with its loss. Regentis Biomaterials’ GelrinC is designed to support the body’s natural cartilage-regeneration process through a gradual, controlled repair environment. Early clinical data has provided encouraging evidence for GelrinC, which already has approval in Europe, while an FDA-authorized pivotal trial is advancing its development toward potential U.S. approval. A knee that once carried a runner through marathons or a hiker up a steep mountainside can be sidelined by a single defect in cartilage. More broadly,…

Site Search

Company Search